Skip to main content

View full-text article in PMC

. 2016 Sep 29;13(1):136–143. doi: 10.1080/21645515.2016.1234555

Table 3B.

ELISA anti-PT, anti-FHA and anti-PRN IgG Geometric Mean Titers at baseline and 7 and 28 d after vaccination.

	PT			FHA			PRN
	Baseline	Day 7	Day 28	Baseline	Day 7	Day 28	Baseline	Day 7	Day 28
	GMT (IU/mL)(95% CI)	GMT (IU/mL)(95% CI)	GMT (IU/mL)(95% CI)	GMT (IU/mL)(95% CI)	GMT (IU/mL)(95% CI)	GMT (IU/mL)(95% CI)	GMT (IU/mL)(95% CI)	GMT (IU/mL)(95% CI)	GMT (IU/mL)(95% CI)
Vaccine
BNA's aP	6.98 (5.37–9.07)	31.38 (12.92–76.24)	264.0^b (113.70–612.92)	12.57 (8.27–19.11)	130.2^b (78.59–215.62)	728.0^b (545.94–970.66)	9.20 (5.84–14.47)	28.77 (11.95–69.31)	120.4 (51.57–280.90)
BNA's TdaP	10.00 (5.78–17.31)	41.46 (17.67–97.29)	268.5^b (162.20–444.39)	15.50 (8.95–26.84)	154.0^b (102.66–230.90)	666.1^b (498.61–889.79)	7.91 (5.63–11.13)	29.73 (14.31–61.79)	118.3 (59.02–237.11)
Adacel®	6.77 (5.43–8.44)	25.98 (16.54–40.80)	50.79^a (36.98–69.75)	16.64 (11.05–25.05)	60.38^a (43.22–84.36)	159.6^a (114.49–222.49)	8.48 (6.33–11.37)	49.46 (21.32–114.75)	175.0 (77.51–395.11)
P-value	0.226	0.655	<0.001^*	0.640	0.004^*	<0.001^*	0.835	0.548	0.708

P-value based on One-way ANOVA,

^*

P < 0.05, statistically significant.